Osteoporosis Treatments

Find Osteoporosis Treatments

Generic Name

Alendronate

Brand Names
Fosamax, Binosto
FDA approval date: February 06, 2008
Classification: Bisphosphonate
Form: Tablet, Solution

What is Fosamax (Alendronate)?

Alendronate sodium tablets are a bisphosphonate indicated for: Treatment and prevention of osteoporosis in postmenopausal women.
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances

Related Clinical Trials

A Feasibility Study of Alendronate as Treatment for Osteonecrosis in Adults With Sickle Cell Disease

Summary: A prospective, single-arm, intervention study of oral alendronate in adults with sickle cell disease and osteonecrosis

A Randomized, Placebo-controlled, Double-blind Trial to Study the Effects of Etidronate on Ectopic CALCIfication in FAhr's Disease or Syndrome

Summary: Fahr's disease or syndrome are neurodegenerative diseases in which patients present with bilateral vessel associated calcifications in the basal ganglia. The clinical penetration of Fahr's disease or syndrome is incomplete and heterogeneous comprising of neuropsychiatric signs, cognitive decline, movement disorders, and various other signs (migraine, speech disorders, pain, seizures). The symptoms...

The Bone, Exercise, Alendronate, and Caloric Restriction Trial

Summary: The purpose of this research is to identify strategies that minimize bone loss that occurs when older adults lose weight. Participation in this research will involve up to nine assessment visits and last up to two years.

Brand Information